KAHR-104

N/A

Report date: 2024/07/30 15:45:06

Base Information

Drug NameKAHR-104
Drug Alias NameKAHR-104
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor necrosis factor ligand superfamily member 4 modulatorsTNF-related apoptosis-inducing ligand receptors modulators
TargetsTumor necrosis factor ligand superfamily member 4TNF-related apoptosis-inducing ligand receptors
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKahr Medical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKahr Medical
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A